Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, FVT

Lilly Announces Webcast to Discuss World Conference on Lung Cancer Presentation


INDIANAPOLIS, Aug. 19, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will conduct a webcast on Monday, September 9, 2019 to discuss data presented for its RET-Inhibitor, LOXO-292, at the 20th meeting of the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer in Barcelona, Spain. Remarks will focus on registrational results from the LIBRETTO-001 trial, a Phase 1/2 trial of LOXO-292 in patients with RET fusion-positive lung cancers. The webcast will begin at 7:00 p.m. Central European Time, or 1:00 p.m. Eastern Time.

Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/events.cfm. A replay will also be available on the website following the conference call.

About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels.  F-LLY   

Refer to:

Mark Taylor; mark.taylor@lilly.com; (317) 276-5795 (Media)


Kevin Hern; hern_kevin_r@lilly.com; (317) 277-1838 (Investors)

 

Eli Lilly and Company logo. (PRNewsfoto/Eli Lilly and Company)

 

SOURCE Eli Lilly and Company


These press releases may also interest you

at 01:47
Stonebranch Inc., a leading provider of dynamic IT automation solutions, today announced that Makedonski Telekom, North Macedonia's leading telecom provider, selected Stonebranch to manage and automate applications in support of real-time charging...

at 01:35
Regulatory News: Lysogene (Paris:LYS) (FR0013233475 ? LYS), a pioneering Phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track...

at 01:22
Itiviti, a leading technology and service provider to financial institutions worldwide, today announced that its multi-asset trading and execution solution has won  Best Trading and Execution Platform at the 5th Asian Private Banker Technology...

at 01:20
Halozyme Therapeutics, Inc. today announced that the U.S. Food and Drug Administration has accepted a Biologics License Application (BLA) from Genentech, a member of the Roche Group, for the fixed-dose combination of pertuzumab (Perjeta®) and...

at 01:06
Chroma ATE launches complete test solutions for True Wireless Stereo (TWS) chips, incorporating wireless RF and MCU tests as well as digital, analog, and mixed-signal measurements. The economical Chroma 3380 test systems satisfy price-conscious IC...

at 01:05
Renesas Electronics Corporation (TSE:6723, "Renesas"), a premier supplier of advanced semiconductor solutions, today announced that it has resolved at the Meeting of Board of Directors held on February 25, 2020 to authorize an acquisition of own...



News published on 19 august 2019 at 16:15 and distributed by: